Optimizerx Corp
A maker of digital health tools that connect drugmakers with doctors and patients inside the electronic health record (EHR) software clinicians already use. Its platform lets pharmaceutical brands send doctors practical messages at the moment of prescribing—covering new therapies, medication adherence, and copay assistance. Founded in 2006 by entrepreneur David A. Harrell, the company got its name from its mission to "optimize" the prescription (Rx) process, and it grew out of an earlier firm renamed in 2008. Its point-of-care messaging appears in thousands of EHR and e-prescribing systems used across the country.
Granted 123.2K · Bought 36.1K · Sold 100.0K
Granted 73.8K · Bought 327.4K
Granted 372.7K · Bought 3.2K · Sold 54.6K
Granted 142.1K · Bought 3.0K
Granted 73.8K
Granted 73.8K
Granted 174.4K · Bought 1.0K · Sold 4.0K
Granted 16.1K
Granted 73.8K · Sold 17.4K
Granted 48.6K · Sold 48.6K
Granted 59.2K
Granted 74.9K
Granted 56.1K
Granted 68.0K
Granted 20.0K · Sold 40.0K
Granted 30.3K
Granted 68.0K
Granted 771
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Febbo William JCEO, Director · 23 transactions | +10.3% | 600.9Kas of Feb 2025 | 123.2K | 36.1K | 100.0K |
| Lang James PaulDirector · 10 transactions | +1228.3% | 433.8K | 73.8K | 327.4K | — |
| Silvestro Stephen LChief Executive Officer · 36 transactions | — | 183.6K | 372.7K | 3.2K | 54.6K |
| Stelmakh EdwardChief Finance & Strat Officer · 23 transactions | — | 121.8K | 142.1K | 3.0K | — |
| Vos Ellen O'ConnorDirector · 8 transactions | +225.8% | 107.2K | 73.8K | — | — |
| Wasson Gregory DDirector · 8 transactions | +411.4% | 91.7K | 73.8K | — | — |
| Odence-Ford MarionChief Legal & Admin Officer · 40 transactions | — | 90.4K | 174.4K | 1.0K | 4.0K |
| Halas Gus DDirector · 5 transactions | +24.8% | 80.9Kas of Jun 2024 | 16.1K | — | — |
| Spangler Patrick DDirector · 10 transactions | +252.5% | 78.7K | 73.8K | — | 17.4K |
| Paramore Miriam JPRESIDENT AND CSO · 8 transactions | 0% | 74.6Kas of Dec 2021 | 48.6K | — | 48.6K |
| Greco TheresaChief Commercial Officer · 10 transactions | — | 72.0K | 59.2K | — | — |
| Besch DougChief Product & Tech Officer · 15 transactions | — | 66.9K | 74.9K | — | — |
| Klema CathyDirector · 4 transactions | — | 56.1K | 56.1K | — | — |
| D'Silva Andrew J.Chief Business Officer · 7 transactions | — | 43.5K | 68.0K | — | — |
| Baker Douglas PCHIEF FINANCIAL OFFICER · 10 transactions | -36.5% | 34.8Kas of Oct 2021 | 20.0K | — | 40.0K |
| Presti Mariyamma VargheseDirector · 2 transactions | — | 30.3K | 30.3K | — | — |
| Merrell Brendan W.CHIEF OPERATING OFFICER · 6 transactions | — | 25.2K | 68.0K | — | — |
| Inman ToddChief Technology Officer · 2 transactions | — | 771as of Mar 2023 | 771 | — | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over the last 5 years: +106.2K shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.